Androgen receptor footprint on the way to prostate cancer progression (Q26825402)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Androgen receptor footprint on the way to prostate cancer progression	scientific article

Statements

instance of

scholarly article

1 reference

stated in

PubMed

review article

1 reference

stated in

PubMed

retrieved

25 January 2021

title

Androgen receptor footprint on the way to prostate cancer progression (English)

1 reference

stated in

PubMed

main subject

intracellular receptor

1 reference

stated in

PubMed

retrieved

21 December 2019

prostate neoplasm

3 references

stated in

PubMed

retrieved

26 August 2020

stated in

PubMed

retrieved

29 October 2020

stated in

PubMed

retrieved

25 January 2021

signal transduction

1 reference

stated in

PubMed

retrieved

26 August 2020

disease progression

1 reference

stated in

PubMed

retrieved

29 October 2020

androgen receptor

1 reference

stated in

PubMed

retrieved

25 January 2021

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Myles C. Hodgson

series ordinal

1

1 reference

stated in

Crossref

Wayne A. Bowden

series ordinal

2

1 reference

stated in

Crossref

Irina U. Agoulnik

series ordinal

3

1 reference

stated in

Crossref

language of work or name

English

1 reference

stated in

PubMed

publication date

June 2012

1 reference

stated in

PubMed

1 June 2012

5 references

stated in

PubMed Central

retrieved

3 April 2019

stated in

PubMed Central

retrieved

21 December 2019

stated in

PubMed Central

retrieved

26 August 2020

stated in

PubMed Central

retrieved

29 October 2020

stated in

PubMed Central

retrieved

25 January 2021

published in

World Journal of Urology

6 references

stated in

PubMed

stated in

PubMed Central

retrieved

3 April 2019

stated in

PubMed Central

retrieved

21 December 2019

stated in

PubMed Central

retrieved

26 August 2020

stated in

PubMed Central

retrieved

29 October 2020

stated in

PubMed Central

retrieved

25 January 2021

volume

30

1 reference

stated in

PubMed

issue

3

1 reference

stated in

PubMed

page(s)

279-85

1 reference

stated in

PubMed

copyright license

Creative Commons Attribution-NonCommercial 2.0 Generic

start time

17 September 2011

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

7 April 2017

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

7 April 2017

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

7 April 2017

Molecular determinants of resistance to antiandrogen therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

7 April 2017

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

7 April 2017

Integrative genomic profiling of human prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

7 April 2017

Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Cytokine disbalance in common human cancers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Coactivator selective regulation of androgen receptor activity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

AR, the cell cycle, and prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Nuclear receptor coregulators and human disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Inflammation in prostate carcinogenesis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Recent results: biomarkers of aging

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Androgen receptor action in hormone-dependent and recurrent prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

SRC-3 is required for prostate cancer cell proliferation and survival

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Alterations of androgen receptor in prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Mutation of the androgen receptor causes oncogenic transformation of the prostate

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 September 2017

Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

31 May 2018

Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

31 May 2018

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

31 May 2018

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00345-011-0743-7

retrieved

21 January 2018

Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00345-011-0743-7

retrieved

21 January 2018

Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00345-011-0743-7

retrieved

21 January 2018

The prognostic value of E-cadherin and the cadherin-associated molecules α-, β-, γ-catenin and p120ctn in prostate cancer specific survival: A long-term follow-up study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00345-011-0743-7

retrieved

21 January 2018

E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3360873

retrieved

28 November 2018

Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21927983

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-level expression of forkhead-box protein A1 in metastatic prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21927983

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00345-011-0743-7

0 references

Dimensions Publication ID

1006147273

0 references

PMC publication ID

3360873

1 reference

stated in

PubMed

PubMed publication ID

21927983

1 reference

stated in

PubMed

ResearchGate publication ID

51652209

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26825402&oldid=2177271497"